Dynatronics to Attend the NDC Exhibition 2019
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / April 4, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of athletic training,...
user
Bankole A. Johnson, M.D., Chief Medical Officer of Adial Pharmaceuticals Delivers Keynote Lecture; Receives Prestigious American Society of Addiction Medicine Award
Lecture to focus on pharmacogenic treatment personalization for alcohol use disorder CHARLOTTESVILLE, VA / ACCESSWIRE / April 4, 2019 /...
DECN Hails Completion of Its Genultimate! TBG Panacea System, 3rd Party Testing to Begin in Next 7 Days, Clinical Trials Testing to Begin in May
Equity Fund in Stealthy Move Tried to Gain Control of DECN In March, Just as a Big Box Was in...
Alimera Sciences Announces Expansion of Leadership Team with Appointment of Samer Kaba, MD as Chief Medical Officer
ATLANTA, GA / ACCESSWIRE / April 4, 2019 / Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a leader in the commercialization...
Milestone Scientific Enters Medical Education Market, Inks Distribution Agreement with American 3B Scientific
New CompuFlo® Epidural Trainer Connects Technique and Intelligence to Improve Trainee Success LIVINGSTON, NJ / ACCESSWIRE / April 4, 2019...
Oncolytics Biotech(R) to Host Key Opinion Leader Meeting on the Emerging Role of Biomarkers and Oncolytic Viruses in the Treatment of Cancer
Meeting and webcast scheduled for Thursday, April 11 in New York City CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE...
Angle PLC Announces AACR 2019
Angle's Parsortix System Showcased in Six Poster Presentations at Leading Cancer Conference AACR 2019 Customers publish data from four independent...
NeoGenomics Schedules its First Quarter Earnings Release for April 30, 2019
FT. MYERS, FL / ACCESSWIRE / April 3, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
GeneNews Announces Q4 2018 Results and Provides Progress Update
Company Builds Momentum with Launch of Patient Directed Cancer Testing; Gains Ground in Population Health Initiatives with Health Systems and...
Kadmon to Present at the H.C. Wainwright Global Life Sciences Conference
NEW YORK, NY / ACCESSWIRE / April 3, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Harlan W....
Adial Pharmaceuticals Announces Open Market Purchases of Common Stock by Chief Medical Officer, Bankole Johnson, M.D.
CHARLOTTESVILLE, VA / ACCESSWIRE / April 3, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused...
VistaGen Therapeutics to Participate in the William Blair 3rd Annual Late-Stage Therapeutics Conference on April 4, 2019
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / April 3, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
ENDRA Life Sciences Receives ISO 13485 Certification
ANN ARBOR, MI / ACCESSWIRE / April 3, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of...
Oncolytics Biotech(R) to Present at the 18th Annual Needham Healthcare Conference
CALGARY, AB and SAN DIEGO, CA / ACCESSWIRE / April 3, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC),...
CORRECTION: GeneNews Announces Fourth Quarter 2018 Results and Year End Investor Call
In the news release, "GeneNews Announces Fourth Quarter 2018 Results and Year End Investor Call", issued April 2, 2019 by...
An Advisor Friendly HSA Solution
PEORIA, IL / ACCESSWIRE / April 3, 2019 / MyHSA announced a strategic partnership and collaboration today, debuting a truly...
NeoGenomics to Present at 18th Annual Needham & Company Health Care Conference
FT. MYERS, FLORIDA / ACCESSWIRE / April 2, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
GeneNews Closes CDN $510,000 Second Tranche of Strategic Private Placement
TORONTO, ON / ACCESSWIRE / April 2, 2019 / GeneNews Limited (TSX: GEN) ("GeneNews" or the "Company") today announced that...
Orchestra BioMed(TM) to Present at the 2019 Bioelectronic Medicine Forum
Panel presentation will provide an overview and outlook on BackBeat Cardiac Neuromodulation Therapy, a potent, novel bioelectronic treatment for hypertension...
Easton Announces Signing of Joint Venture Agreement for the Purchase and Development of 9 Townhomes with Revenue in Excess of $4 Million and Provides Update on its Framing Contract with Revenues of $770K for Q1
TORONTO, ON / ACCESSWIRE / April 2, 2019 / Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Announces that is has signed...